Prelude Capital Management, LLC Novo Cure LTD Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $224,959 - $457,334	-19,016 Reduced 60.39%	12,471 $213,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $391,068 - $544,410	31,487 New	31,487 $492,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $162,289 - $271,786	-1,397 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $16,039 - $27,746	-123 Reduced 8.09%	1,397 $310,000
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $35,247 - $54,008	284 Added 22.98%	1,520 $201,000
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $70,699 - $91,970	1,236 New	1,236 $73,000
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $988,074 - $1.48 Million	-23,403 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $57,911 - $101,689	-1,812 Reduced 7.19%	23,403 $1.13 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $33,142 - $60,735	-1,154 Reduced 4.38%	25,215 $844,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $8,480 - $13,886	-265 Reduced 0.99%	26,369 $1.38 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $42,101 - $67,872	2,121 Added 8.65%	26,634 $834,000
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $40,935 - $50,161	-2,121 Reduced 7.96%	24,513 $534,000
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $279,919 - $376,088	17,173 Added 181.51%	26,634 $538,000
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $170,771 - $205,776	9,461	9,461 $188,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.